Kyung Taek Oh - Search Results

Year	Number of Results
2007	3
2008	4
2009	3
2010	9
2011	14
2012	12
2013	5
2014	7
2016	10
2017	21
2018	19
2019	13
2020	14
2021	9
2022	5
2023	11
2024	2

1

Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment.

Husni P, Lim C, Oh KT. Husni P, et al. Among authors: oh kt. Int J Pharm. 2023 May 25;639:122942. doi: 10.1016/j.ijpharm.2023.122942. Epub 2023 Apr 8. Int J Pharm. 2023. PMID: 37037397 Review.

2

Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer.

Yoon J, Le XT, Kim J, Lee H, Nguyen NT, Lee WT, Lee ES, Oh KT, Choi HG, Youn YS. Yoon J, et al. Among authors: oh kt. J Control Release. 2023 Aug;360:482-495. doi: 10.1016/j.jconrel.2023.07.009. Epub 2023 Jul 12. J Control Release. 2023. PMID: 37423526

3

Principles and applications of nanomaterial-based hyperthermia in cancer therapy.

Kang JK, Kim JC, Shin Y, Han SM, Won WR, Her J, Park JY, Oh KT. Kang JK, et al. Among authors: oh kt. Arch Pharm Res. 2020 Jan;43(1):46-57. doi: 10.1007/s12272-020-01206-5. Epub 2020 Jan 28. Arch Pharm Res. 2020. PMID: 31993968 Review.

4

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.

Hong SS, Oh KT, Choi HG, Lim SJ. Hong SS, et al. Among authors: oh kt. Pharmaceutics. 2019 Oct 17;11(10):540. doi: 10.3390/pharmaceutics11100540. Pharmaceutics. 2019. PMID: 31627301 Free PMC article. Review.

5

Particle-in-Particle Platform for Nanoconfinement-Induced Oncothermia.

Yoo E, Choi JH, Hoang NH, Lee JS, Vuong S, Hur B, Han P, Oh KT, Fahmy T, Kim D. Yoo E, et al. Among authors: oh kt. ACS Appl Bio Mater. 2018 Dec 17;1(6):1927-1941. doi: 10.1021/acsabm.8b00490. Epub 2018 Nov 19. ACS Appl Bio Mater. 2018. PMID: 34996256

6

Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.

Ruttala HB, Ramasamy T, Madeshwaran T, Hiep TT, Kandasamy U, Oh KT, Choi HG, Yong CS, Kim JO. Ruttala HB, et al. Among authors: oh kt. Arch Pharm Res. 2018 Feb;41(2):111-129. doi: 10.1007/s12272-017-0995-x. Epub 2017 Dec 6. Arch Pharm Res. 2018. PMID: 29214601 Review.

7

pH-Responsive hyaluronated liposomes for docetaxel delivery.

Lee JM, Park H, Oh KT, Lee ES. Lee JM, et al. Among authors: oh kt. Int J Pharm. 2018 Aug 25;547(1-2):377-384. doi: 10.1016/j.ijpharm.2018.06.028. Epub 2018 Jun 11. Int J Pharm. 2018. PMID: 29902507

8

The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system.

Oh KT, Baik HJ, Lee AH, Oh YT, Youn YS, Lee ES. Oh KT, et al. Int J Mol Sci. 2009 Aug 31;10(9):3776-3792. doi: 10.3390/ijms10093776. Int J Mol Sci. 2009. PMID: 19865518 Free PMC article. Review.

9

Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis.

Lee E, Park J, Youn YS, Oh KT, Kim D, Lee ES. Lee E, et al. Among authors: oh kt. Biomedicines. 2020 Nov 11;8(11):492. doi: 10.3390/biomedicines8110492. Biomedicines. 2020. PMID: 33187133 Free PMC article.

10

pH-Sensitive Twin Liposomes Containing Quercetin and Laccase for Tumor Therapy.

Kim Y, Oh KT, Youn YS, Lee ES. Kim Y, et al. Among authors: oh kt. Biomacromolecules. 2022 Sep 12;23(9):3688-3697. doi: 10.1021/acs.biomac.2c00571. Epub 2022 Aug 17. Biomacromolecules. 2022. PMID: 35977087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year